Metlife Inc. buy Morgan Stanley
Summary
This prediction ended on 16.04.25 with a price of €63.96. With a performance of -2.49%, the BUY prediction for Metlife Inc. by Morgan_Stanley closed slightly in the red. Morgan_Stanley has a follow-up prediction for Metlife Inc. where he still thinks Metlife Inc. is a Buy. A total of €2.03 was paid as dividends for this prediction. Morgan_Stanley has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Metlife Inc. | -0.117% | -0.117% | -13.990% |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% |
Comments by Morgan_Stanley for this prediction
In the thread Metlife Inc. diskutieren
In the thread Trading Metlife Inc.